Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004988491 | SCV005619037 | uncertain significance | Inborn genetic diseases | 2024-07-16 | criteria provided, single submitter | clinical testing | The p.V484I variant (also known as c.1450G>A), located in coding exon 13 of the LRRK2 gene, results from a G to A substitution at nucleotide position 1450. The valine at codon 484 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Based on the available evidence, the clinical significance of this variant remains unclear. |